Research > ETFs > ETF / ETP Commentary > 

Top Performing Leveraged/Inverse ETFs: 09/13/2026

Top Performing Levered/Inverse ETFs Last WeekThese were last week’s top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly. Always do your homework.1. GMEU – T-REX 2X Long GME Daily Target ETF GMEU, which aims to provide 2x leveraged exposure to the daily price movement of GameStop Corp. stock (NYSE: GME) topped the levered ETFs list with over 20% weekly gains. GameStop stock is surging after its CEO bought $20.4 million in shares on the open market boosting investor confidence following a strong earnings report. 2. MSTZ – T-Rex 2X Inverse MSTR Daily Target ETF MSTZ aims to provide inverse exposure to the daily price movement of Strategy Inc. stock (NASDAQ: MSTR) ranked second on the inverse ETFs list with ~17% returns in the last week. Strategy shares dipped last week due to a weakening cryptocurrency market and management’s decision to pause Bitcoin purchases while prioritizing preferred stock buybacks. 3. AMDL – GraniteShares 2x Long AMD Daily ETF AMDL, which provides 2x leveraged exposure to the daily price movement for shares of Advanced Micro Devices stock, also made it to the levered ETFs’ list, with ~16% weekly gains. Advanced Micro Devices stock rose last week after the company gave a strong and optimistic update at the Citi 2026 Global TMT Conference around higher data center goals, larger AI market share, and increased demand. 4. QCML – GraniteShares 2x Long QCOM Daily ETF QCML, which provides 2x leveraged exposure, less fees and expenses, to the daily price movement for shares of Qualcomm Inc.(QCOM) stock, featured on the list. Qualcomm stock increased last week due to a major multi-generation artificial intelligence infrastructure partnership with Amazon Web Services (AWS). 5. LABD – Direxion Daily S&P Biotech Bear 3X ETF LABD provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index, also made it to the list. The biotech sector fell last week primarily due to negative clinical trial results from major industry players like Novartis, which triggered widespread investor nervousness. 6. DLLL – GraniteShares 2x Long DELL Daily ETF DLLL, which provides 2x leveraged exposure to the daily price movement for shares of Dell Technologies Inc. stock, was present on the list. Dell Technologies shares surged due to massive AI infrastructure demand, strong earnings, and bullish analyst coverage. 7. INTW – GraniteShares 2x Long INTC Daily ETF INTW, which provides 2x leveraged exposure to the daily price movement for shares of Intel Corporation (INTC) stock, was another leveraged candidate on the list with nearly 14% weekly gains. Intel shares gained over recent days due to several factors including positive analyst upgrades, reports of upcoming CPU price hikes, and strong server demand tied to artificial intelligence. 8. YANG – Direxion Daily FTSE China Bear 3X ETF YANG offers 3x daily short leverage to the FTSE China 50 Index and is featured on the list of levered/ inverse ETFs returning over 12% last week. China’s stock market faced downward pressure due to a mix of domestic economic imbalances, cooling consumer demand, and regional tech sector weakness. 9. FLYD – MicroSectors Travel -3x Inverse Leveraged ETN FLYD, which tracks -3x the daily price movements of an index of US-listed travel-related companies, also ranked among the weekly list of inverse ETFs with ~11% returns, due to rising fuel costs, renewed geopolitical tensions, and broader concerns over a weakening consumer economy. 10. MRAL – GraniteShares 2x Long MARA Daily ETF MRAL provides 2x leveraged exposure to the daily price movement for shares of MARA Holdings, Inc. (MARA) stock, and was present on the list. MARA shares increased last week driven by ongoing buzz around its strategic pivot into AI and high-performance computing (HPC) data center infrastructure. For more news, information, and analysis, visit the Leveraged & Inverse Content Hub.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.